15 Technology Product Development Grants, Worth $4.2M, Approved by Mtech Maryland Industrial Partnerships Program
The Maryland Industrial Partnerships Program (MIPS), a historically effective innovation development program in the State of Maryland, has approved 15 new high-technology and biotechnology product development grants worth $4.2 million.
Among the projects are new drugs, treatments or tests for breast cancer, staph infections and malaria, "green" heated chicken house flooring, a dual-use, dual-powered motorized cycle, superior quality glucosamine, and a stylish plug-in electric hybrid car.
"Our number one priority is to create jobs in this new economy," says Maryland Governor Martin O'Malley. "The Maryland Industrial Partnerships Program invests in innovation, enabling us to improve our quality of life and create jobs for the next generation of businesses in Maryland."
The grants combine $3.2 million from participating companies and $1 million from MIPS. The Maryland Department of Natural Resources and the Environmental Protection Agency provided additional funding for select MIPS projects.
MIPS, an initiative of the Maryland Technology Enterprise Institute (Mtech) at the University of Maryland, provides grants for commercially promising technology product development projects that partner Maryland companies with researchers in Maryland public universities. Both companies and MIPS contribute money, all of which supports the work of faculty and graduate students.
Companies and faculty for each project include:
This is the 48th round of MIPS funding. Six projects are in Montgomery County, three are on the Eastern Shore, two are in the Baltimore area, two are in Columbia, one is in College Park and one is in southern Maryland. Eight of the projects will take place at the University of Maryland, College Park, three at the University of Maryland, Baltimore and two each at both the University of Maryland, Baltimore County, and the University of Maryland, Eastern Shore.
Blockbuster and life-changing products developed by Maryland companies have benefitted from MIPS, including Martek Biosciences' nutritional oils, Hughes Communications' HughesNet, MedImmune's Synagis, Black & Decker's Bullet Speed Tip Masonry Drill Bit, WellDoc's mobile diabetes management platform, and CSA Medical's diseased-tissue ablation device. Products with MIPS projects have generated more than $21.6 billion in revenue and added thousands of jobs to the region.
MIPS has supported research projects with nearly 500 different Maryland companies since 1987.
Projects are subject to final contract negotiations.
Ten of the projects will take place at the University of Maryland, College Park, while one will occur at each of the following institutions: Frostburg State University, Towson University, the University of Maryland, Baltimore, University of Maryland, Baltimore County, University of Maryland Center for Environmental Science, and the University of Maryland, Eastern Shore.
August 10, 2011